89bio Inc.

NASDAQ: ETNB · Real-Time Price · USD
9.22
0.12 (1.32%)
At close: Aug 15, 2025, 3:59 PM
9.23
0.05%
After-hours: Aug 15, 2025, 04:10 PM EDT

89bio Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-367.08M -142.19M -102.03M -90.12M
Depreciation & Amortization
-9.14M 50K 65K 79K
Stock-Based Compensation
20.63M 16.11M 10.36M 8.68M
Other Working Capital
-21.59M 4.57M 4.9M -1.53M
Other Non-Cash Items
2.29M -3.94M -41K 1.48M
Deferred Income Tax
n/a 127K n/a -150K
Change in Working Capital
-14.53M 657K 10.56M 3.25M
Operating Cash Flow
-367.82M -129.19M -81.09M -76.78M
Capital Expenditures
-15K -4K -7K -63K
Cash Acquisitions
n/a n/a 33.94K -7.22K
Purchase of Investments
-376.07M -341.15M -152.7M -141.2M
Sales Maturities Of Investments
335.23M 218.13M 118.76M 148.42M
Other Investing Acitivies
n/a n/a -33.94K 7.22K
Investing Cash Flow
-40.86M -123.02M -33.94M 7.16M
Debt Repayment
9.35M 2.96M n/a 19.95M
Common Stock Repurchased
n/a 268K n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
51.66M 13.58M 834K 144K
Financial Cash Flow
218.59M 513.11M 117.83M 23.87M
Net Cash Flow
-190.1M 260.91M 2.8M -45.75M
Free Cash Flow
-367.84M -129.19M -81.1M -76.84M